Aster DM Healthcare Ltd., a leading healthcare provider in the Gulf Cooperation Council (GCC) and India, announced strong financial performance for both the fourth quarter (Q4FY24) and the full fiscal year 2024 (FY24).
Q4FY24 Financial Highlights:
Revenue: ₹978 crore (22% YoY growth)
Operating EBITDA: ₹167 crore (24% YoY growth)
FY24 Financial Highlights:
Revenue: ₹3,699 crore (24% YoY growth)
Operating EBITDA: ₹620 crore (30% YoY growth)
PBT (Profit Before Tax): ₹281 crore (34% YoY growth)
Adjusted PAT: ₹240 crore (63% YoY growth)
Reported PAT: ₹188 crore (28% YoY growth)
Key Points:
Robust Growth: Aster DM Healthcare experienced significant growth in revenue and profitability across all its segments and geographies in both Q4FY24 and FY24.
India Performance: The India business witnessed strong performance with a 44% YoY increase in revenue for the full year, driven by robust growth in the hospitals and retail segments.
GCC Performance: The GCC business also exhibited a 14% YoY increase in revenue, showcasing continued growth in this key market.
Expansion and Acquisitions: The company is expanding its presence in India through strategic acquisitions and greenfield projects.
Dividend: The Board of Directors recommended a final dividend of ₹2.00 per equity share for FY24.
Additional Information:
The Q4FY24 and FY24 results reflect Aster DM Healthcare's commitment to providing high-quality healthcare services and its successful expansion strategy.
The company remains optimistic about its future growth prospects and expects to continue its momentum in the coming years.
For further analysis and information, you can refer to the following resources:
ICICI Direct Analysis: https://www.icicidirect.com/research/equity/rapid-results/aster-dm-healthcare-ltd
Aster DM Healthcare Investor Relations: https://www.asterdmhealthcare.com/investors/financial-information/annual-reports
5paisa Share Price: https://www.5paisa.com/stocks/asterdm-share-price
留言